StreetInsider.com News Articles

SpineGuard Obtains a New U.S. Patent for Its Innovative Ultrasound Technology Designed to Determine the Entry Point and Pedicular Drilling Trajectory

Mon, 24 Aug 2026 12:00:00 -0400

The ideal complement to DSG's real-time, X-ray-free guidance technology
Seeking industrial partnerships

PARIS--(BUSINESS WIRE)-- Regulatory News:

SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its digital surgical guidance (DSG®) technology—which measures the electrical conductivity of tissues locally in real time—to ensure the safe and simplified placement of bone implants, announced today that it has been granted a new U.S. patent by the USPTO (U.S. Patent and Trademark Office) for a robotically assisted ultrasound technology designed to determine the entry point and pedicle drilling trajectory from the bony surface of the spine.

Stéphane Bette, Deputy CEO and Co-founder of SpineGuard,

SpineGuard Obtains a New U.S. Patent for Its Innovative Ultrasound Technology Designed to Determine the Entry Point and Pedicular Drilling Trajectory

Mon, 24 Aug 2026 12:00:00 -0400

The ideal complement to DSG's real-time, X-ray-free guidance technology

Seeking industrial partnerships

PARIS--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its digital surgical guidance (DSG®) technology—which measures the electrical conductivity of tissues locally in real time—to ensure the safe and simplified placement of bone implants, announced today that it has been granted a new U.S. patent by the USPTO (U.S. Patent and Trademark Office) for a robotically assisted ultrasound technology designed to determine the entry point and pedicle drilling trajectory from the bony surface of the spine.
Stéphane Bette, Deputy CEO and Co-founder of SpineGuard,

SpineGuard Obtains a New U.S. Patent for Its Innovative Ultrasound Technology Designed to Determine the Entry Point and Pedicular Drilling Trajectory

Mon, 24 Aug 2026 12:00:00 -0400

The ideal complement to DSG's real-time, X-ray-free guidance technology

Seeking industrial partnerships

PARIS--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its digital surgical guidance (DSG®) technology—which measures the electrical conductivity of tissues locally in real time—to ensure the safe and simplified placement of bone implants, announced today that it has been granted a new U.S. patent by the USPTO (U.S. Patent and Trademark Office) for a robotically assisted ultrasound technology designed to determine the entry point and pedicle drilling trajectory from the bony surface of the spine.
Stéphane Bette, Deputy CEO and Co-founder of SpineGuard,

SpineGuard Obtains a New U.S. Patent for Its Innovative Ultrasound Technology Designed to Determine the Entry Point and Pedicular Drilling Trajectory

Mon, 24 Aug 2026 12:00:00 -0400

The ideal complement to DSG's real-time, X-ray-free guidance technology

Seeking industrial partnerships

PARIS--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its digital surgical guidance (DSG®) technology—which measures the electrical conductivity of tissues locally in real time—to ensure the safe and simplified placement of bone implants, announced today that it has been granted a new U.S. patent by the USPTO (U.S. Patent and Trademark Office) for a robotically assisted ultrasound technology designed to determine the entry point and pedicle drilling trajectory from the bony surface of the spine.
Stéphane Bette, Deputy CEO and Co-founder of SpineGuard,

SpineGuard Obtains a New U.S. Patent for Its Innovative Ultrasound Technology Designed to Determine the Entry Point and Pedicular Drilling Trajectory

Mon, 24 Aug 2026 12:00:00 -0400

The ideal complement to DSG's real-time, X-ray-free guidance technology

Seeking industrial partnerships

PARIS--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its digital surgical guidance (DSG®) technology—which measures the electrical conductivity of tissues locally in real time—to ensure the safe and simplified placement of bone implants, announced today that it has been granted a new U.S. patent by the USPTO (U.S. Patent and Trademark Office) for a robotically assisted ultrasound technology designed to determine the entry point and pedicle drilling trajectory from the bony surface of the spine.
Stéphane Bette, Deputy CEO and Co-founder of SpineGuard,

SpineGuard Obtains a New U.S. Patent for Its Innovative Ultrasound Technology Designed to Determine the Entry Point and Pedicular Drilling Trajectory

Mon, 24 Aug 2026 12:00:00 -0400

The ideal complement to DSG's real-time, X-ray-free guidance technology

Seeking industrial partnerships

PARIS--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its digital surgical guidance (DSG®) technology—which measures the electrical conductivity of tissues locally in real time—to ensure the safe and simplified placement of bone implants, announced today that it has been granted a new U.S. patent by the USPTO (U.S. Patent and Trademark Office) for a robotically assisted ultrasound technology designed to determine the entry point and pedicle drilling trajectory from the bony surface of the spine.
Stéphane Bette, Deputy CEO and Co-founder of SpineGuard,

SpineGuard Obtains a New U.S. Patent for Its Innovative Ultrasound Technology Designed to Determine the Entry Point and Pedicular Drilling Trajectory

Mon, 24 Aug 2026 12:00:00 -0400

The ideal complement to DSG's real-time, X-ray-free guidance technology

Seeking industrial partnerships

PARIS--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its digital surgical guidance (DSG®) technology—which measures the electrical conductivity of tissues locally in real time—to ensure the safe and simplified placement of bone implants, announced today that it has been granted a new U.S. patent by the USPTO (U.S. Patent and Trademark Office) for a robotically assisted ultrasound technology designed to determine the entry point and pedicle drilling trajectory from the bony surface of the spine.
Stéphane Bette, Deputy CEO and Co-founder of SpineGuard,

SpineGuard Obtains a New U.S. Patent for Its Innovative Ultrasound Technology Designed to Determine the Entry Point and Pedicular Drilling Trajectory

Mon, 24 Aug 2026 12:00:00 -0400

The ideal complement to DSG's real-time, X-ray-free guidance technology

Seeking industrial partnerships

PARIS--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its digital surgical guidance (DSG®) technology—which measures the electrical conductivity of tissues locally in real time—to ensure the safe and simplified placement of bone implants, announced today that it has been granted a new U.S. patent by the USPTO (U.S. Patent and Trademark Office) for a robotically assisted ultrasound technology designed to determine the entry point and pedicle drilling trajectory from the bony surface of the spine.
Stéphane Bette, Deputy CEO and Co-founder of SpineGuard,

SpineGuard and Omnia Medical Obtain a New U.S. Patent for Their Innovative Application of DSG Technology to Sacroiliac Joint Fusion

Mon, 27 Jul 2026 12:00:00 -0400

Innovation codeveloped in partnership

Acceleration of commercial deployment in the United States

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company specializing in Dynamic Surgical Guidance (DSG®) technology to enhance the safety and efficiency of bone implant placement, and Omnia Medical, an orthopedic implant company focused on innovative spine and sacroiliac solutions, today announced that their U.S. patent application has received notice of allowance from the USPTO (United States Patent and Trademark Office) for their innovative application of DSG technology to sacroiliac joint fusion.
The recently allowed patent applications by the USPTO, applied jointly by

SpineGuard and Omnia Medical Obtain a New U.S. Patent for Their Innovative Application of DSG Technology to Sacroiliac Joint Fusion

Mon, 27 Jul 2026 12:00:00 -0400

Innovation codeveloped in partnership

Acceleration of commercial deployment in the United States

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company specializing in Dynamic Surgical Guidance (DSG®) technology to enhance the safety and efficiency of bone implant placement, and Omnia Medical, an orthopedic implant company focused on innovative spine and sacroiliac solutions, today announced that their U.S. patent application has received notice of allowance from the USPTO (United States Patent and Trademark Office) for their innovative application of DSG technology to sacroiliac joint fusion.
The recently allowed patent applications by the USPTO, applied jointly by

SpineGuard and Omnia Medical Obtain a New U.S. Patent for Their Innovative Application of DSG Technology to Sacroiliac Joint Fusion

Mon, 27 Jul 2026 12:00:00 -0400

Innovation codeveloped in partnership

Acceleration of commercial deployment in the United States

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company specializing in Dynamic Surgical Guidance (DSG®) technology to enhance the safety and efficiency of bone implant placement, and Omnia Medical, an orthopedic implant company focused on innovative spine and sacroiliac solutions, today announced that their U.S. patent application has received notice of allowance from the USPTO (United States Patent and Trademark Office) for their innovative application of DSG technology to sacroiliac joint fusion.
The recently allowed patent applications by the USPTO, applied jointly by

SpineGuard and Omnia Medical Obtain a New U.S. Patent for Their Innovative Application of DSG Technology to Sacroiliac Joint Fusion

Mon, 27 Jul 2026 12:00:00 -0400

Innovation codeveloped in partnership

Acceleration of commercial deployment in the United States

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company specializing in Dynamic Surgical Guidance (DSG®) technology to enhance the safety and efficiency of bone implant placement, and Omnia Medical, an orthopedic implant company focused on innovative spine and sacroiliac solutions, today announced that their U.S. patent application has received notice of allowance from the USPTO (United States Patent and Trademark Office) for their innovative application of DSG technology to sacroiliac joint fusion.
The recently allowed patent applications by the USPTO, applied jointly by

SpineGuard Announces its H1 2026 Revenue

Wed, 08 Jul 2026 12:00:00 -0400

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced its first half 2026 revenue.
Pierre Jérôme, Co-founder, Chairman and CEO of SpineGuard, stated:
“Revenue for the first half of the year is in line with our roadmap. Our DSG technology is increasingly establishing itself as the efficient and reliable alternative to navigation systems and robots, whose cost and associated constraints limit their adoption by practitioners and hospitals.
In the United States, the transitional effects

SpineGuard Announces its H1 2026 Revenue

Wed, 08 Jul 2026 12:00:00 -0400

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced its first half 2026 revenue.
Pierre Jérôme, Co-founder, Chairman and CEO of SpineGuard, stated:
“Revenue for the first half of the year is in line with our roadmap. Our DSG technology is increasingly establishing itself as the efficient and reliable alternative to navigation systems and robots, whose cost and associated constraints limit their adoption by practitioners and hospitals.
In the United States, the transitional effects

SpineGuard Announces its H1 2026 Revenue

Wed, 08 Jul 2026 12:00:00 -0400

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced its first half 2026 revenue.
Pierre Jérôme, Co-founder, Chairman and CEO of SpineGuard, stated:
“Revenue for the first half of the year is in line with our roadmap. Our DSG technology is increasingly establishing itself as the efficient and reliable alternative to navigation systems and robots, whose cost and associated constraints limit their adoption by practitioners and hospitals.
In the United States, the transitional effects

SpineGuard Announces its H1 2026 Revenue

Wed, 08 Jul 2026 12:00:00 -0400

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced its first half 2026 revenue.
Pierre Jérôme, Co-founder, Chairman and CEO of SpineGuard, stated:
“Revenue for the first half of the year is in line with our roadmap. Our DSG technology is increasingly establishing itself as the efficient and reliable alternative to navigation systems and robots, whose cost and associated constraints limit their adoption by practitioners and hospitals.
In the United States, the transitional effects

SpineGuard Obtains Three New Patents for Full Protection in the U.S. of Its Innovative Solutions Integrating DSG Technology

Tue, 26 May 2026 12:00:00 -0400

All patents now granted in the United States to enhance the safety of robots, navigation systems, and powered orthopedic or dental drills

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces that three new U.S. patent applications have received notices of allowance from the USPTO (United States Patent and Trademark Office).
The three recently allowed patent applications by the USPTO form part of a set of five patent families that SpineGuard has

SpineGuard Obtains Three New Patents for Full Protection in the U.S. of Its Innovative Solutions Integrating DSG Technology

Tue, 26 May 2026 12:00:00 -0400

All patents now granted in the United States to enhance the safety of robots, navigation systems, and powered orthopedic or dental drills

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces that three new U.S. patent applications have received notices of allowance from the USPTO (United States Patent and Trademark Office).
The three recently allowed patent applications by the USPTO form part of a set of five patent families that SpineGuard has

SpineGuard Obtains Three New Patents for Full Protection in the U.S. of Its Innovative Solutions Integrating DSG Technology

Tue, 26 May 2026 12:00:00 -0400

All patents now granted in the United States to enhance the safety of robots, navigation systems, and powered orthopedic or dental drills

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces that three new U.S. patent applications have received notices of allowance from the USPTO (United States Patent and Trademark Office).
The three recently allowed patent applications by the USPTO form part of a set of five patent families that SpineGuard has

SpineGuard Obtains Three New Patents for Full Protection in the U.S. of Its Innovative Solutions Integrating DSG Technology

Tue, 26 May 2026 12:00:00 -0400

All patents now granted in the United States to enhance the safety of robots, navigation systems, and powered orthopedic or dental drills

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announces that three new U.S. patent applications have received notices of allowance from the USPTO (United States Patent and Trademark Office).
The three recently allowed patent applications by the USPTO form part of a set of five patent families that SpineGuard has

SpineGuard: Official Launch of Three New PediGuard® Models During the Annual Scoliosis Meeting in China

Tue, 28 Apr 2026 12:00:00 -0400

Presentation of PediGuard in plenary session

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced the official launch of the newly cleared Curved and XS PediGuard models, in Nanjing (China), during the 2026 Chinese Scoliosis Annual Meeting in conjunction with French Spine Society. PediGuard has been highlighted by Professor Helton Defino from Ribeiro Preto (Brazil) during his lecture in plenary session.
Patricia Lempereur, VP of Sales and Marketing at SpineGuard, said: “The

SpineGuard: Official Launch of Three New PediGuard® Models During the Annual Scoliosis Meeting in China

Tue, 28 Apr 2026 12:00:00 -0400

Presentation of PediGuard in plenary session

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced the official launch of the newly cleared Curved and XS PediGuard models, in Nanjing (China), during the 2026 Chinese Scoliosis Annual Meeting in conjunction with French Spine Society. PediGuard has been highlighted by Professor Helton Defino from Ribeiro Preto (Brazil) during his lecture in plenary session.
Patricia Lempereur, VP of Sales and Marketing at SpineGuard, said: “The

SpineGuard: Official Launch of Three New PediGuard® Models During the Annual Scoliosis Meeting in China

Tue, 28 Apr 2026 12:00:00 -0400

Presentation of PediGuard in plenary session

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced the official launch of the newly cleared Curved and XS PediGuard models, in Nanjing (China), during the 2026 Chinese Scoliosis Annual Meeting in conjunction with French Spine Society. PediGuard has been highlighted by Professor Helton Defino from Ribeiro Preto (Brazil) during his lecture in plenary session.
Patricia Lempereur, VP of Sales and Marketing at SpineGuard, said: “The

SpineGuard: Official Launch of Three New PediGuard® Models During the Annual Scoliosis Meeting in China

Tue, 28 Apr 2026 12:00:00 -0400

Presentation of PediGuard in plenary session

PARIS & BOULDER, Colo.--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 - ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today announced the official launch of the newly cleared Curved and XS PediGuard models, in Nanjing (China), during the 2026 Chinese Scoliosis Annual Meeting in conjunction with French Spine Society. PediGuard has been highlighted by Professor Helton Defino from Ribeiro Preto (Brazil) during his lecture in plenary session.
Patricia Lempereur, VP of Sales and Marketing at SpineGuard, said: “The

SpineGuard and Omnia Medical Complete US Asset Transfer and Enter Exclusive Distribution Agreement for PediGuard®

Mon, 13 Apr 2026 12:00:00 -0400

Integration of PediGuard systems into Omnia Medical's portfolio across a broad range of spine indications, including minimally invasive and outpatient treatments

Transaction supports SpineGuard’s objective or reaching operational breakeven by the end of 2026

MORGANTOWN, W. Va. & BOULDER, Colo. & PARIS--(BUSINESS WIRE)-- Regulatory News:
SpineGuard (FR0011464452 – ALSGD), an innovative company specializing in Dynamic Surgical Guidance (DSG®) technology to enhance the safety and efficiency of bone implant placement, and Omnia Medical, an orthopedic implant company focused on innovative spine and sacroiliac solutions, today announced the completion of the transfer of SpineGuard Inc assets and the execution of an